We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Smartwatch-Based Algorithm Detects Early Signs of Viral Infections, Including COVID-19

By HospiMedica International staff writers
Posted on 01 Nov 2021

Researchers have developed a smartwatch-based algorithm to detect early signs of viral infections, including COVID-19. More...

Purdue University (West Lafayette, IN, USA) and physIQ (Chicago, IL, USA) have announced the co-development of a viral detection algorithm for smartwatches. This innovation will be the result of a collaboration between physIQ and university engineers. The algorithm will be commercialized by physIQ, which develops solutions designed to improve health care outcomes by applying artificial intelligence (AI) to real-time physiological data from wearable sensors.

The research involved a study of 100 participants, including Purdue students, staff and faculty, to determine whether wearing a smartwatch to collect data was practical, unobtrusive and user-friendly. Each participant received a Samsung Galaxy smartwatch with a pre-loaded physIQ app to collect data. Along with the smartwatch, they also wore FDA-cleared adhesive chest-based biosensors to capture a single-lead electrocardiogram signal and multiple other parameters for five days of continuous monitoring. The researchers then analyzed data from the app remotely using physIQ's cloud-based accelerateIQ platform.

Data from the chest patches were processed by physIQ's U.S. Food and Drug Administration-cleared AI-based algorithms in deriving heart rate, respiration rate and heart rate variability. These data served as "gold standard" references to compare with data from the smartwatches. The viral infection detection algorithm complements physIQ's other health care applications. The goal across all of physIQ's applications is the ability to characterize dynamic human physiology over time, whether it is for assessing the efficacy of a new therapy, safety monitoring during treatment or general wellness.

"Smartwatches are well-suited for the detection of early viral infection, including COVID-19," said Craig Goergen, Purdue's Leslie A. Geddes Associate Professor of Biomedical Engineering, who led the research. “Infections can happen at any time, making the continuously tracked data available through an individual's smartwatches uniquely suited to identify the earliest signs of illness. In particular, knowledge of a person's usual heart rate and respiratory during sleep and activity over long periods of time is especially valuable for detecting subtle changes from normal.”

"The algorithms for enabling early detection are built off physiological features derived from the biosensor data collected by the smartwatches," said Stephan Wegerich, physIQ's chief science officer. "Generating accurate and robust physiological features forms the input to subsequent viral detection algorithms. This requires the development of sophisticated signal processing and machine learning algorithms. Combined, these make the most out of smartwatch biosensor data, which is a big part of our collaboration with Purdue."

Related Links:
Purdue University 
physIQ 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gas Analyzer
GE SAM
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: 3D-printed nitinol tapered flow-diverter stent with variable fiber density, sectional size and shape. (Photo courtesy of IMDEA Materials Institute)

3D Printing Method Could Enable More Flexible Cardiovascular Implants

Minimally invasive transcatheter devices must compress into small catheters and recover their intended shape after deployment, creating a design challenge for cardiovascular implants with complex, patient-specific... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image: Visual Abstract (Sinuo Gao, Zhaoqi Zhang, Chao Shi, Cheng Cheng, Xindi Ma, Xinming Zhao, Yunjiang Liu Journal of Nuclear Medicine Oct 2026, 67 (10) 1552-1559; DOI: 10.2967/jnumed.125.271529)

Targeted PET/CT Predicts Early Treatment Response in HER2-Positive Breast Cancer

HER2-positive breast cancer is an aggressive subtype that accounts for a substantial proportion of breast cancer cases. Patients often receive neoadjuvant therapy before surgery to shrink tumors, but assessing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.